142 related articles for article (PubMed ID: 19818365)
21. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
22. Investigation of exposure to swine influenza viruses in Ontario (Canada) finisher herds in 2004 and 2005.
Poljak Z; Friendship RM; Carman S; McNab WB; Dewey CE
Prev Vet Med; 2008 Jan; 83(1):24-40. PubMed ID: 17604859
[TBL] [Abstract][Full Text] [Related]
23. [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2209-14. PubMed ID: 17061434
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of influenza surveillance from 2000 to 2007 in Gansu province].
Li HY; Yu DS; Chen JH; Liu XZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Aug; 22(4):266-8. PubMed ID: 19105339
[TBL] [Abstract][Full Text] [Related]
25. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
27. [Type and subtype distribution of influenza virus and genetic evolution of hemagglutinin in Shanghai area in duration of 2004 - 2008].
Yang JX; Ju LW; Jiang LF; Shi Q; Jiang QW; Zhang YY; Zhou YB; Shen HG; Tan YY
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Apr; 43(4):305-8. PubMed ID: 19534952
[TBL] [Abstract][Full Text] [Related]
28. [Antigenic and genetic study of influenza virus circulated in China in 2006].
Zhang Y; Zhao X; Guo JF; Wei HJ; Cheng YH; Li XW; Xu CL; Guo YJ; Shu YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):304-6. PubMed ID: 18322584
[TBL] [Abstract][Full Text] [Related]
29. Subtype identification of the novel A H1N1 and other human influenza A viruses using an oligonucleotide microarray.
Kang X; Li Y; Sun H; Wu W; Liu H; Lin F; Qing C; Chang G; Zhu Q; Chen W; Yang Y
Arch Virol; 2010; 155(1):55-61. PubMed ID: 19998047
[TBL] [Abstract][Full Text] [Related]
30. Surveillance for the 2009 pandemic influenza A (H1N1) virus and seasonal influenza viruses - New Zealand, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(33):918-21. PubMed ID: 19713880
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the usefulness of the CACO-2 cell line with standard substrates for isolation of swine influenza A viruses.
Chiapponi C; Zanni I; Garbarino C; Barigazzi G; Foni E
J Virol Methods; 2010 Jan; 163(1):162-5. PubMed ID: 19781571
[TBL] [Abstract][Full Text] [Related]
32. [Influenza activity in China from 2000 to 2001].
Zhang Y; Li Z; Guo JF; Wang M; Wen LY; Guo YJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jan; 24(1):4-8. PubMed ID: 12678953
[TBL] [Abstract][Full Text] [Related]
33. Modelling control measures to reduce the impact of pandemic influenza among schoolchildren.
Chen SC; Liao CM
Epidemiol Infect; 2008 Aug; 136(8):1035-45. PubMed ID: 17850689
[TBL] [Abstract][Full Text] [Related]
34. Molecular and phylogenetic analysis of human influenza virus among Iranian patients in Shiraz, Iran.
Shahidi M; Kheiri MT; Amini-Bavil-Olyaee S; Hosseini M; Moattari A; Tabatabaeian M; Bashar R; Sarrami-Forooshani R; Mahboudi F
J Med Virol; 2007 Jun; 79(6):803-10. PubMed ID: 17457914
[TBL] [Abstract][Full Text] [Related]
35. Using surveillance to evaluate influenza vaccine effectiveness.
Jackson LA
J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
[No Abstract] [Full Text] [Related]
36. Preparing the outbreak assistance laboratory network in the Netherlands for the detection of the influenza virus A(H1N1) variant.
Meijer A; Beerens A; Claas E; Hermans M; de Jong A; Molenkamp R; Niesters H; Overduin P; Rossen J; Schuurman R; Wolffs P; Fouchier R; Osterhaus A; Schutten M; Koopmans M
J Clin Virol; 2009 Jul; 45(3):179-84. PubMed ID: 19540155
[TBL] [Abstract][Full Text] [Related]
37. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
[TBL] [Abstract][Full Text] [Related]
38. The molecular epidemiology of influenza viruses: a lesson from a highly epidemic season.
D'Agaro P; Rossi T; Burgnich P; Molin GD; Coppola N; Rocco G; Campello C
J Clin Pathol; 2008 Mar; 61(3):355-60. PubMed ID: 17630401
[TBL] [Abstract][Full Text] [Related]
39. Influenza activity--United States and worldwide, 2007-08 season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(25):692-7. PubMed ID: 18583957
[TBL] [Abstract][Full Text] [Related]
40. Update: influenza activity--United States, September 28, 2008-April 4, 2009, and composition of the 2009-10 influenza vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Apr; 58(14):369-74. PubMed ID: 19373198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
